Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury
about
Is lipid signaling through cannabinoid 2 receptors part of a protective system?Physical activity and the endocannabinoid system: an overviewCannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury.Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathyCannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathyβ-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complicationsCannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell lineΔ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injuryMitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants.Drug-induced mitochondrial dysfunction and cardiotoxicity.Investigational A₃ adenosine receptor targeting agents.Modulating the endocannabinoid system in human health and disease--successes and failuresModulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischaemic myocardium and synergestic effects of resveratrol and γ-tocotrienol.Cannabinoids: novel therapies for arthritis?Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection.Downstream effects of endocannabinoid on blood cells: implications for health and disease.Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.The Role of the Endocannabinoid System in the Brain-Gut Axis.Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability.β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats.Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users.The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension
P2860
Q24633122-0E8639C6-8C15-4B81-83A3-230D4E827CBCQ28307668-68FA7CFB-0FC2-490B-8A07-FA356B5E894BQ34851941-59CA8A83-35FA-47B3-BA1A-28713EF1C221Q35514172-9625F795-06FB-4DDC-8D49-1E6453698406Q35659099-3983DDF2-083D-4A67-95CC-7540EB867855Q35707221-857BA766-6BC2-4BA6-9972-2B01987C227AQ35766956-8427A78D-537E-4F39-9669-911447F4C5FBQ35854652-9751E1C3-263D-4324-BF7D-107211128FA2Q35951992-2C6CFB78-C9B9-41C2-B6E9-76CD57373E33Q36032332-BCA802E8-BFF7-43C6-9ED2-33ACEB8C07EBQ36176486-D034CBDA-8BE2-48A5-83CF-E45F6640BA51Q36176499-53EDD407-2FA0-4288-8DBB-EC5CE2B794D9Q36203242-2A088576-C974-49FA-96EC-14CC574840B1Q36339445-D864FFF9-0617-410B-8829-F828DA9A94EBQ36731575-F975351B-C366-4DF5-9AC2-2EB7E3381F6AQ36933683-79098470-C4EB-4299-9AA6-227F3088EC6AQ37296261-4384D1E8-DF9B-4684-8AE0-08A4859B47D0Q38005189-12063A7C-70BD-4802-B559-983BCB0613C0Q38135915-F81DF03A-A16D-4411-8D55-C3E75CFD01FDQ38468985-1F5031A7-DB9C-4951-A9FF-BDC3FFF7689CQ38684679-3AC4D32E-A10B-4BBA-B5E0-404F80C97EB4Q38822341-A5345CC3-3960-457A-90F8-0CEF337CA476Q41963239-5B6EBE7F-0372-447B-B535-2E23E8871F35Q42272971-2DDE0C9D-37F0-4F4F-9010-22829039C63DQ48238653-667EA2CA-13FE-4814-BFDB-87A4E8B23D5EQ55312720-18B6F4FE-9EDA-4F93-AFF1-C56751568B18Q58696656-4E29C91C-82C6-49D6-9C33-B53DE43CF4BD
P2860
Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Fatty acid amide hydrolase is ...... duced myocardial tissue injury
@ast
Fatty acid amide hydrolase is ...... duced myocardial tissue injury
@en
Fatty acid amide hydrolase is ...... duced myocardial tissue injury
@nl
type
label
Fatty acid amide hydrolase is ...... duced myocardial tissue injury
@ast
Fatty acid amide hydrolase is ...... duced myocardial tissue injury
@en
Fatty acid amide hydrolase is ...... duced myocardial tissue injury
@nl
prefLabel
Fatty acid amide hydrolase is ...... duced myocardial tissue injury
@ast
Fatty acid amide hydrolase is ...... duced myocardial tissue injury
@en
Fatty acid amide hydrolase is ...... duced myocardial tissue injury
@nl
P2093
P2860
P1476
Fatty acid amide hydrolase is ...... duced myocardial tissue injury
@en
P2093
Bėla Horváth
Galin Tanchian
György Haskó
Keita Saito
Mohanraj Rajesh
Pál Pacher
Rachel Y Gao
Shingo Matsumoto
Sándor Bátkai
Vivek Patel
P2860
P304
P356
10.1016/J.FREERADBIOMED.2010.11.002
P407
P577
2011-01-01T00:00:00Z